Delivery Order SPE2DB24D2106-SPE2DB25FAWLW
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,456.01 by the Defense Logistics Agency (DLA) on August 13, 2025. The contract calls for the delivery of Cosentyx Unoready 300 mg pen 2ml pharmaceutical product to a location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 18, 2025, for Cosentyx Unoready 300 mg pen 2 ml pharmaceutical products. The contract is valued at $16,800.32 under a firm fixed-price arrangement with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, leveraging the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, received a delivery order valued at $23.5K from the Defense Logistics Agency (DLA) on June 16, 2025, for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This firm fixed-price delivery order, with an ultimate completion date of June 17, 2025, was awarded without set-aside designation and will be performed in Conshohocken, Pennsylvania. The award falls under DMS Pharmaceutical Group's...
- On June 2, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,807.94 to DMS Pharmaceutical Group Inc. for the supply of Cosentyx (secukinumab) 300mg dose-2 pen/ml. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with performance at its Conshohocken, Pennsylvania location. The award carries no set-aside designation, and the delivery order is scheduled for ultimate...
- The Defense Logistics Agency awarded a $10.79K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 16, 2025. The delivery order calls for Cosentyx Unoready 300 mg pen 2ml, a prescription biologic medication used to treat autoimmune conditions, with performance completion scheduled for September 17, 2025. The contract carries no set-aside designation and will be performed at the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $19,259.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300mg dose-2 pen/ml pharmaceutical products. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, does not utilize a set-aside designation. Performance will be executed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,911.80 contract is for the delivery of Cosentyx Unoready 300 mg pens to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order from the Defense Logistics Agency (DLA), a defense agency, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a firm fixed price of $39,295.74 and a completion date of June 18, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
- On August 20, 2025, the Defense Logistics Agency awarded a delivery order valued at $10,461.10 to DMS Pharmaceutical Group Inc. for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injections. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract does not utilize a set-aside designation, and the pharmaceutical products will be...
- The Defense Logistics Agency (DLA) awarded a $5,015.29 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300mg dose injections. This firm fixed-price delivery order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a single-unit pharmaceutical procurement with no set-aside designation. The product will be delivered to...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWLWDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 15, 2025, by the Defense Logistics Agency (DLA) for Cosentyx Unoready 300 mg pen 2ml supplies. The contract, valued at $21.5K with a firm fixed-price structure, carries an ultimate completion date of September 16, 2025, with performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. This delivery order was awarded without a set-aside designation, enabling DMS Pharmaceutical Group to compete on an unrestricted basis within the federal marketplace. This award represents a delivery order issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.9M and valid through November 2026. The IDC authorizes the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide, including branded and generic prescription drugs, biologics, and medical consumables. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group continues to provide essential medications and specialty pharmaceuticals directly to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.5k | 9/15/25 |